✦ LIBER ✦

Castration plus nilutamide vs castration plus placebo in advanced prostate cancer: A Review

✍ Scribed by Dionisius J. Du Plessis

Book ID: 119046797
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 712 KB
Volume: 37
Category: Article
ISSN: 0090-4295
DOI: 10.1016/0090-4295(91)80097-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic Factor Analysis in Patients w

Prognostic Factor Analysis in Patients with Advanced Prostate Cancer Treated by Castration Plus Anandron or Placebo: A Final Update

✍ Theo M. de Reijke; Eric Derobert 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 369 KB

Efficacy of Oxaliplatin Plus Pemetrexed

Efficacy of Oxaliplatin Plus Pemetrexed in Chemotherapy Pretreated Metastatic Castration-Resistant Prostate Cancer

✍ Dorff, Tanya B.; Tsao-Wei, Denice D.; Groshen, Susan; Boswell, William; Goldkorn 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 391 KB

Carboplatin plus paclitaxel therapy afte

Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer

✍ Stephanie Jeske; Scott T. Tagawa; Olugbenga Olowokure; Jodi Selzer; Paraskevi Gi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Randomized, Placebo-Controlled, Phase II

Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer

✍ Michaelson, M. Dror (author);Oudard, Stephane (author);Houede, Nadine (author);M 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 219 KB

Randomized, Placebo-Controlled, Phase II

Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer

✍ Michaelson, M. Dror (author);Oudard, Stephane (author);Houede, Nadine (author);M 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 219 KB

Carboplatin plus weekly docetaxel as sal

Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer

✍ Christoph W. M. Reuter; Michael A. Morgan; Philipp Ivanyi; Martin Fenner; Arnold 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 359 KB